Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Specialty Devices
Drug Delivery Devices
Return to: MDBR Home | Specialty Devices | Drug Delivery Devices

Drug Delivery Devices

EMA approves Aptar Pharma’s electronic lockout device Aptar Pharma, a world leader in innovative drug delivery systems, has announced the approval by the European Medicines Agency (EMA) of the first integrated electronic nasal lockout device (e-Lockout) following a multi-year development with Takeda Pharmaceuticals International.
Specialty Devices > Drug Delivery Devices > News
QT Vascular signs asset purchase option agreement with Medtronic QT Vascular has entered into an asset purchase option agreement with Medtronic, for the acquisition of its non-drug coated Chocolate PTA.
Specialty Devices > Drug Delivery Devices > News FDA approves Medtronic’s Resolute Onyx drug-eluting stent By MDBR Staff Writer
Medtronic has secured approval from the US Food and Drug Administration (FDA) for its Resolute Onyx drug-eluting stent (DES).
Specialty Devices > Drug Delivery Devices > News
See more Drug Delivery Devices news

Latest Drug Delivery Devices News and Insight

View all Drug Delivery Devices news or find news targeted to your interests
Lubrizol : Invests $60 Million to Expand Particle Sciences, Vesta and Other Facilities in 2017
Lubrizol LifeSciences continues to invest in its key capabilities. During this latest phase, a $60 million investment will focus on new product solutions, capacity expansion and additional cGMP manufacturing.
Specialty Devices > Drug Delivery Devices > Press Releases
The miniature servo controller for extreme conditions - maxon motor
A rugged, compact powerhouse: The new ESCON Module 50/8 HE servo controller from maxon motor controls DC motors up to 750 W, even in the harshest ambient conditions.
Specialty Devices > Drug Delivery Devices > Press Releases
Lubrizol LifeSciences-From Polymers through Production, your Total Solution Provider
Lubrizol LifeSciences is a healthcare solution partner that provides customer support from idea to execution by supplying customizable polymers and excipients, complex drug formulation development and best-in-class contract manufacturing services for medical device and pharmaceutical manufacturers.
Specialty Devices > Drug Delivery Devices > Suppliers
EMA approves Aptar Pharma’s electronic lockout device
Aptar Pharma, a world leader in innovative drug delivery systems, has announced the approval by the European Medicines Agency (EMA) of the first integrated electronic nasal lockout device (e-Lockout) following a multi-year development with Takeda Pharmaceuticals International.
Specialty Devices > Drug Delivery Devices > News
View all Drug Delivery Devices news or find news targeted to your interests